SCHEMBL3947235

SCHEMBL3947235

CC(C)(C)OC(=O)N1C[C@@H](O)C[C@@H]1CN1C(=O)c2ccccc2C1=O

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
RIPK1 Q13546 1/20 0.39
SRC P12931 5/20 0.38
BRD4 O60885 4/20 0.38
HSD11B1 P28845 1/20 0.36
TP53 P04637 1/20 0.36
NAMPT P43490 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
NR1H2 P55055 2/20 0.35
NR1H3 Q13133 2/20 0.35
IDO1 P14902 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8572979 1.00 CYP1A2 (0.43) CYP1A2POLBCYP3A4CYP2C19RIPK1
SCHEMBL3948769 0.90 SRC (0.40) CYP1A2POLBCYP3A4CYP2C19SRC
SCHEMBL20783314 0.90 SRC (0.40) CYP1A2POLBCYP3A4CYP2C19SRC
SCHEMBL19674208 0.88 HSD17B10 (0.40) SRCBRD4HSD11B1TP53NAMPT
SCHEMBL19540703 0.87 HSD11B1 (0.38) SRCBRD4HSD11B1TP53NAMPT
SCHEMBL3389544 0.87 JAK2 (0.38) SRCBRD4HSD11B1TP53NAMPT
SCHEMBL263737 0.87 JAK2 (0.38) SRCBRD4HSD11B1TP53NAMPT
SCHEMBL7807928 0.85 BRD4 (0.39) SRCBRD4HSD11B1NR1H2NR1H3
SCHEMBL3952747 0.85 BRD4 (0.39) SRCBRD4HSD11B1NR1H2NR1H3
SCHEMBL7800302 0.84 ECE1 (0.37) SRCBRD4HSD11B1TP53MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009026197-A1 NOVEL CATHEPSIN C INHIBITORS AND THEIR USE GLAXO GROUP LIMITED (GB) 2009-02-26 WO disclosed
WO-2009026197-A1 NOVEL CATHEPSIN C INHIBITORS AND THEIR USE GLAXO GROUP LIMITED (GB) 2009-02-26 WO disclosed